Recent Updates

Published: 
Mar 22, 2017
Chapter 6

All blood transfused in Canada is collected from volunteer donors. To ensure the safety of the blood products, donors are carefully screened against an extended list of eligibility criteria and their donated blood products are tested for transfusion-transmissible diseases. Donor eligibility criteria also reduce potential health risks for the donor. This chapter describes the donor selection process, the pathogen testing done on blood products, and the pathogen inactivation processes that can further reduce the potential risk of transfusion-transmitted diseases.

Transfusion
Published: 
Mar 31, 2017
Chapter 7

Background

Originally all plasma fractionation products were derived from pooled human plasma. Increasingly, many plasma proteins are manufactured by biotechnology as recombinant proteins, without need of donated plasma; depending on the particular plasma protein product, a recombinant or a fractionated product or both are available in Canada.

This Chapter presents in general terms the various methods and principles by which plasma protein products are manufactured for use in patients. It is complemented by Chapter 3, 4, 5 and 6 of this Guide.

Transfusion
Published: 
May 31, 2017
Chapter 16

This chapter focuses on preoperative autologous donation (PAD). There are other types of autologous blood use (e.g. acute normovolemic hemodilution and intraoperative and postoperative blood salvage) which are not discussed in this chapter.

PAD refers to the donation of blood by a patient for his/her own future use; generally this is for a scheduled elective surgery. The top three procedures associated with a request for a PAD are total hip replacement, total knee replacement and hysterectomy.

In most cases, allogeneic blood transfusions are a safe and available option. Autologous and directed donations should be confined to circumstances of rare blood types or plasma protein deficiencies in which  allogeneic units may not meet patient needs. Rare blood types represent only a small number of autologous units collected each year.

Transfusion

Upcoming Events

When
September 25, 2017 | 8:00AM to 4:00PM
Where

Lord Nelson Hotel, Halifax

Theme    : “Breaking Down Barriers”
When      : September 25, 2017  (8am - 16:00 pm)
Where     : Lord Nelson Hotel, Halifax 
Program : Program at a Glance Save the Date

Organs and Tissues
When
October 2, 2017 | 8:00AM to October 5, 2017 | 5:00PM
Where

Toronto

The Critical Care Canada Forum 2017 is Canada's national critical care meeting. Held over 4 days, it focuses on clinicians, scientists, and leaders in critical care medicine, and attracts the best speakers worldwide. CCCF consists of superlative plenary talks, thematic sessions and posters, with exhibits that demonstrate the latest products and services. 

Featuring internationally renowned experts; Darren Freed (Canada), Stephen Large (UK), Peter MacDonald (Australia), Paul Murphy (UK), and Robert TRuog (USA). 

Transfusion
Organs and Tissues
When
October 7, 2017 | 8:00AM to October 10, 2017 | 6:00PM
Where

San Diego, California

The AABB Annual Meeting is the premiere event for healthcare professionals in the fields of transfusion medicine and cellular therapies.

Click here for more information.

Transfusion
Stem Cells

Blog

Global matters

Modified on: 
Sep 20, 2017

Paying it forward: Why we need YOU to give blood - Part 4

red blood cells

Modified on: 
Sep 13, 2017

Paying it forward: Why we need YOU to give blood - Part 3

blood on the move

Modified on: 
Sep 6, 2017

By Lisa Bendall, Health Writer